Adtalem Global 2025 Q4 Earnings Strong Performance as Net Income Surges 9.7%

Adtalem Global (ATGE) reported its fiscal 2025 Q4 earnings on August 7, 2025. The company surpassed expectations with robust revenue and earnings growth. While the company did not revise its guidance, it maintained an optimistic outlook for 2026.

Revenue
Adtalem Global reported total revenue of $457.11 million in fiscal 2025 Q4, reflecting an 11.5% increase compared to $409.91 million in the same period of the prior year. This growth highlights the company's continued expansion across its education and workforce development platforms.

Earnings/Net Income
The company’s earnings per share (EPS) grew by 15.1% year-over-year to $1.51 from $1.31 in 2024 Q4. Net income also rose by 9.7% to $54.21 million in 2025 Q4, compared to $49.42 million in 2024 Q4, reinforcing its improving profitability. These results indicate a strong earnings performance.

Price Action
The stock price of Adtalem Global edged up 0.29% during the latest trading day and climbed 4.34% during the most recent full trading week. However, it edged down 0.64% month-to-date.

Post-Earnings Price Action Review
A strategy of buying Adtalem Global shares following the company’s positive Q4 earnings report and holding for 30 days has historically yielded impressive returns. Over the past three years, this strategy delivered a 173.21% return, significantly outperforming the 49.71% benchmark return. With a compound annual growth rate (CAGR) of 41.21% and a maximum drawdown of 0.00%, the strategy demonstrated strong risk-adjusted performance and minimal downside risk.

CEO Commentary
Steve Beard, Chairman and CEO of Adtalem Global Education, described fiscal 2025 as a defining inflection point for the company. He praised the results under the Growth with Purpose strategy and emphasized the company’s commitment to disciplined investments, strategic partnerships, and improved student outcomes. Beard expressed confidence in Adtalem’s ability to deliver long-term value for students, shareholders, and the healthcare system.

Guidance
Adtalem provided fiscal 2026 guidance with revenue expected to range between $1,900 million and $1,940 million, and adjusted earnings per share projected to be between $7.60 and $7.90. The company reiterated its focus on operational efficiency and enrollment growth, with continued momentum in key segments such as Chamberlain, Walden, and Medical and Veterinary programs. No specific guidance was provided for GAAP metrics or enrollment growth.

Additional News
Adtalem Global Education is a leading workforce solutions provider committed to empowering students and professionals in the medical and healthcare fields. The company operates multiple institutions, including Chamberlain University, Ross University School of Medicine, and Walden University, and partners with organizations to address future workforce needs. Adtalem is also focused on sustainability and governance, with initiatives in environmental practices, community engagement, and responsible business conduct. The company recently emphasized its mission to expand global access to education and training programs that support career development and healthcare delivery.